Literature DB >> 3347828

The period prevalence of musculoskeletal complaints among Swedish professional drivers.

G E Hedberg1.   

Abstract

The aim of the investigation was to survey the period prevalence of musculoskeletal complaints among Swedish professional drivers. 460 out of 570 male drivers answered a postal inquiry. The period prevalence of musculoskeletal complaints was highest for the low back, the shoulders, the knees and the neck, in that order. For some parts of the musculoskeletal system the period prevalence of complaints tended to increase with age. A subdivision of the examined group of drivers according to task revealed--after standardizing for age (SRR)--different relative risk of complaints in various anatomical regions of the body. The interaction among some variables was studied by means of Automatic Interaction Detection Analysis. The analysis showed that the variables age and task reduced the variance of the period prevalence of musculoskeletal complaints most.

Entities:  

Mesh:

Year:  1988        PMID: 3347828     DOI: 10.1177/140349488801600102

Source DB:  PubMed          Journal:  Scand J Soc Med        ISSN: 0300-8037


  3 in total

1.  Lorry drivers' work stress evaluated by catecholamines excreted in urine.

Authors:  A J van der Beek; T F Meijman; M H Frings-Dresen; J I Kuiper; S Kuiper
Journal:  Occup Environ Med       Date:  1995-07       Impact factor: 4.402

2.  Epidemiological study to investigate potential interaction between physical and psychosocial factors at work that may increase the risk of symptoms of musculoskeletal disorder of the neck and upper limb.

Authors:  J J Devereux; I G Vlachonikolis; P W Buckle
Journal:  Occup Environ Med       Date:  2002-04       Impact factor: 4.402

3.  Comparative effect of driving side on low back pain due to Repetitive Ipsilateral Rotation.

Authors:  Syed Asadullah Arslan; Mohammad Reza Hadian; Gholamreza Olyaei; Saeed Talebian; Mir Saeed Yekaninejad; Mir Arif Hussain
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.